|
PRKRA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.287660E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.461900E-02 |
| Normal-vs-Stage2 |
1.289530E-02 |
| Normal-vs-Stage3 |
3.325700E-02 |
| Normal-vs-Stage4 |
7.187700E-02 |
| Stage1-vs-Stage2 |
1.558650E-01 |
| Stage1-vs-Stage3 |
6.573800E-01 |
| Stage1-vs-Stage4 |
8.853800E-01 |
| Stage2-vs-Stage3 |
3.442600E-01 |
| Stage2-vs-Stage4 |
3.037200E-01 |
| Stage3-vs-Stage4 |
8.547400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.232500E-02 |
| Normal-vs-AfricanAmerican |
4.452600E-01 |
| Normal-vs-Asian |
9.951600E-01 |
| Caucasian-vs-AfricanAmerican |
3.414600E-01 |
| Caucasian-vs-Asian |
2.213900E-02 |
| AfricanAmerican-vs-Asian |
5.337800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.975880E-02 |
| Normal-vs-Female |
2.394500E-02 |
| Male-vs-Female |
4.673200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.005600E-02 |
| Normal-vs-Age(41-60Yrs) |
8.035600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.865730E-02 |
| Normal-vs-Age(81-100Yrs) |
6.686000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.832200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.496400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.955200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.660800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.873400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.941600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.574400E-01 |
| Classical-VS-Follicular |
9.399700E-03 |
| Classical-VS-Other |
1.981400E-01 |
| Classical-VS-Normal |
1.728610E-01 |
| Tall-VS-Follicular |
2.083500E-02 |
| Tall-VS-Other |
1.662450E-01 |
| Tall-VS-Normal |
7.803400E-01 |
| Follicular-VS-Other |
9.826000E-01 |
| Follicular-VS-Normal |
2.217300E-03 |
| Other-VS-Normal |
7.990500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.374000E-04 |
| Normal-vs-N1 |
3.338000E-02 |
| N0-vs-N1 |
4.476400E-01 |
|
|
